Immunogenicity and protective efficacy of a Streptococcus suis vaccine composed of six conserved immunogens

Table 2 Evaluation of protection induced by multicomponent vaccine after intranasal challenge with S. suis cps14 strain V3117/2

Immunization	Morbidity	Mortality	Mean Clinical score (SD)	Clinical signs			Max. body temperature (°C)
Immunization	Morbidity		Mean Clinical score (SD)	CNS^a	Lameness	No feed intake	< 40	≥ 40 and ≤ 40.2	> 40.2
Placebo	4/8	2/8	7 (11.1)	0/8	2/8	2/8	4/8	0/8	4/8
Vaccine	5/8	3/8	11 (12.0)	1/8	3/8	3/8	3/8	1/8	4/8

^aSigns of central nervous system (CNS) dysfunction such as convulsions and opisthotonus.

ISSN: 1297-9716